Evidence map›Paper›PMID 22400069›Full record

ArticlePloS one2012

Reactive oxygen species suppress cardiac NaV1.5 expression through Foxo1.

Weike Mao, Tao You, Bo Ye, Xiang Li, Henry H Dong, Joseph A Hill, Faqian Li, Haodong Xu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. A Possible Role of Tetrodotoxin-Sensitive NaInternational journal of molecular sciences · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Cardiomyocyte Deletion ofFrontiers in physiology · 2021
    Article
  9. Review
  10. A small-molecule LF3 abrogates β-catenin/TCF4-mediated suppression of NaJournal of molecular and cellular cardiology · 2019
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2014
    Review
  18. Article
  19. Article
  20. Elevated nuclear Foxo1 suppresses excitability of skeletal muscle fibers.American journal of physiology. Cell physiology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Weike MaoDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA.
Tao You
Bo Ye
Xiang Li
Henry H Dong
Joseph A Hill
Faqian Li
Haodong Xu
University of Rochester · USUniversity of Rochester Medical Center · USThe University of Texas Southwestern Medical Center · USUniversity of Pittsburgh · US

Funding

HDAC Inhibition in Cardiac Hypertrophy and FailureR01HL080144 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HILL, JOSEPH A · 2007 to 2011
$2.0M
Nuclear beta-catenin signaling in the heartR01HL111480 · NHLBI · UNIVERSITY OF ROCHESTER · PI LI, FAQIAN · 2012 to 2016
$1.9M
Calcineurin-Mediated Regulation of Cardiac Ca2+ ChannelR01HL075173 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HILL, JOSEPH A · 2005 to 2009
$1.7M
Foxo: Negative Regulator of Cardiac HypertrophyR01HL090842 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI HILL, JOSEPH A · 2009 to 2012
$1.6M
Foxo1 in Triglyceride MetabolismR01DK066301 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONG, HENGJIANG HENRY · 2006 to 2010
$1.3M
FoxO6 in Glucose MetabolismR01DK087764 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DONG, HENGJIANG HENRY · 2010 to 2013
$1.3M
Role of Modulation of Ito,f by Kinases in Cardiac DysrhythmiasK08HL088127 · NHLBI · UNIVERSITY OF ROCHESTER · PI XU, HAODONG · 2007 to 2011
$621k
NHLBI NIH HHS HL-075173NHLBI NIH HHS HL-080144NHLBI NIH HHS HL-090842NHLBI NIH HHS K08 HL088127NHLBI NIH HHS K08HL088127NHLBI NIH HHS R01 HL075173NHLBI NIH HHS R01 HL080144NHLBI NIH HHS R01 HL090842NHLBI NIH HHS R01 HL111480NIDDK NIH HHS DK066301NIDDK NIH HHS DK087764NIDDK NIH HHS R01 DK066301NIDDK NIH HHS R01 DK087764
6 · The paper itself

Abstract

Na(V)1.5 is a cardiac voltage-gated Na(+) channel αsubunit and is encoded by the SCN5a gene. The activity of this channel determines cardiac depolarization and electrical conduction. Channel defects, including mutations and decrease of channel protein levels, have been linked to the development of cardiac arrhythmias. The molecular mechanisms underlying the regulation of Na(V)1.5 expression are largely unknown. Forkhead box O (Foxo) proteins are transcriptional factors that bind the consensus DNA sequences in their target gene promoters and regulate the expression of these genes. Comparative analysis revealed conserved DNA sequences, 5'-CAAAACA-3' (insulin responsive element, IRE), in rat, mouse and human SCN5a promoters with the latter two containing two overlapping Foxo protein binding IREs, 5'-CAAAACAAAACA-3'. This finding led us to hypothesize that Foxo1 regulates Na(V)1.5 expression by directly binding the SCN5a promoter and affecting its transcriptional activity. In the present study, we determined whether Foxo1 regulates Na(V)1.5 expression at the transcriptional level and also defined the role of Foxo1 in hydrogen peroxide (H(2)O(2))-mediated Na(V)1.5 suppression in HL-1 cardiomyocytes using chromatin immunoprecipitation (ChIP), constitutively nuclear Foxo1 expression, and RNAi Foxo1 knockdown as well as whole cell voltage-clamp recordings. ChIP with anti-Foxo1 antibody and follow-up semi-quantitative PCR with primers flanking Foxo1 binding sites in the proximal SCN5a promoter region clearly demonstrated enrichment of DNA, confirming Foxo1 recruitment to this consensus sequence. Foxo1 mutant (T24A/S319A-GFP, Foxo1-AA-GFP) was retained in nuclei, leading to a decrease of Na(V)1.5 expression and Na(+) current, while silencing of Foxo1 expression by RNAi resulted in the augmentation of Na(V)1.5 expression. H(2)O(2) significantly reduced Na(V)1.5 expression by promoting Foxo1 nuclear localization and this reduction was prevented by RNAi silencing Foxo1 expression. These studies indicate that Foxo1 negatively regulates Na(V)1.5 expression in cardiomyocytes and reactive oxygen species suppress Na(V)1.5 expression through Foxo1.

Indexed as

AnimalsBase SequenceBlotting, WesternCell Line, TumorCell NucleusCells, CulturedChromatin ImmunoprecipitationForkhead Box Protein O1Forkhead Transcription FactorsGene ExpressionHeLa CellsHumansHydrogen PeroxideMiceMyocytes, CardiacNAV1.5 Voltage-Gated Sodium ChannelForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, mouseHydrogen PeroxideNAV1.5 Voltage-Gated Sodium ChannelOxidantsReactive Oxygen SpeciesSCN5A protein, humanScn5a protein, mouseScn5a protein, ratSodium Channels

Identifiers

PMID22400069
PMCPMC3293505
OpenAlexW2092185159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.